Literature DB >> 25292099

Accuracy of self-checked fecal occult blood testing for colorectal cancer in Thai patients.

Varut Lohsiriwat1.   

Abstract

PURPOSE: Colorectal cancer (CRC) screening with fecal occult blood testing (FOBT) has been associated with a reduction in CRC incidence and CRC-related mortality. However, a conventional FOBT requires stool collection and handling, which may be inconvenient for participants. The EZ-DetectTM (Siam Pharmaceutical Thailand) is a FDA-approved chromogen-substrate based FOBT which is basically a self-checked FOBT (no stool handling required). This study aimed to evaluate the accuracy of EZ-Detect for CRC detection.
METHODS: This prospective study was conducted in the Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand between November 2013 and May 2014. Some 96 patients with histologically-proven CRC and 101 patients with normal colonoscopic findings were invited to perform self-checked FOBT according to the manufacturer's instructions. RESULTS were compared with endoscopic and pathologic findings. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for CRC detection were calculated.
RESULTS: The present study revealed the sensitivity, specificity, PPV and NPV of this self-checked FOBT for CRC detection to be 41% (95% CI: 31-51), 97% (95% CI: 92-99), 93% (95% CI: 81-98) and 63% (95% CI: 55-70), respectively. The overall accuracy of the self-checked FOBT for identifying CRC was 70%. The sensitivity for CRC detection based on 7th AJCC staging was 29% for stage I, 32% for stage II and 50% for stage III/IV (P=0.19). The sensitivity was 33% for proximal colon and 42% for distal colon and rectal cancer (P=0.76). Notably, none of nine infiltrative lesions gave a positive FOBT.
CONCLUSIONS: The self-checked FOBT had an acceptable accuracy of CRC detection except for infiltrative tumors. This home-administrated or 'DIY' do-it-yourself FOBT could be considered as one non-invasive and convenient tool for CRC screening.

Entities:  

Mesh:

Year:  2014        PMID: 25292099     DOI: 10.7314/apjcp.2014.15.18.7981

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  Comprehensive functional genomic analyses link APC somatic mutation and mRNA-miRNA networks to the clinical outcome of stage-III colorectal cancer patients.

Authors:  Sum-Fu Chiang; Heng-Hsuan Huang; Wen-Sy Tsai; Bertrand Chin-Ming Tan; Chia-Yu Yang; Po-Jung Huang; Ian Yi-Feng Chang; Jiarong Lin; Pei-Shan Lu; En Chin; Yu-Hao Liu; Jau-Song Yu; Jy-Ming Chiang; Hsin-Yuan Hung; Jeng-Fu You; Hsuan Liu
Journal:  Biomed J       Date:  2021-03-16       Impact factor: 7.892

2.  High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.

Authors:  Bunchorn Siripongpreeda; Chulabhorn Mahidol; Navara Dusitanond; Tassanee Sriprayoon; Bunlung Muyphuag; Thaniya Sricharunrat; Narongchai Teerayatanakul; Watanya Chaiwong; Wipra Worasawate; Prassanee Sattayarungsee; Juthamas Sangthongdee; Jirapa Prarom; Gaidganok Sornsamdang; Kamonwan Soonklang; Kasiruck Wittayasak; Chirayu U Auewarakul
Journal:  BMC Gastroenterol       Date:  2016-08-23       Impact factor: 3.067

Review 3.  Diagnostic Accuracy of FOBT and Colorectal Cancer Genetic Testing: A Systematic Review & Meta-Analysis.

Authors:  Abdul Rahman Ramdzan; Muhammad Aklil Abd Rahim; Aznida Mohamad Zaki; Zuraidah Zaidun; Azmawati Mohammed Nawi
Journal:  Ann Glob Health       Date:  2019-05-15       Impact factor: 2.462

4.  Dysbiosis of human gut microbiome in young-onset colorectal cancer.

Authors:  Yongzhi Yang; Lutao Du; Debing Shi; Cheng Kong; Jianqiang Liu; Guang Liu; Xinxiang Li; Yanlei Ma
Journal:  Nat Commun       Date:  2021-11-19       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.